POT1 loss-of-function variants predispose to familial melanoma

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Familial melanoma is strongly associated with germline variants in genes like CDKN2A, CDK4, BRCA2, BAP1, and TERT.
• Existing genetic predispositions do not fully explain all familial melanoma cases, necessitating the search for novel susceptibility genes.

Purpose of the Study:

• To identify new high-penetrance susceptibility genes for melanoma in families with a history of the disease.
• To investigate the role of novel genetic variants in melanoma pathogenesis.

Main Methods:

• Whole-exome sequencing of 184 melanoma cases from 105 pedigrees across the UK, Netherlands, and Australia.
• Segregation analysis to identify co-occurrence of variants with melanoma within families.
• Functional studies to assess the impact of identified variants on POT1 protein function and telomere length.

Main Results:

• Identified co-segregation of melanoma with loss-of-function variants in the protection of telomeres 1 (POT1) gene.
• Observed early age of onset and multiple primary tumors in some family members with POT1 variants.
• Demonstrated that POT1 variants affect mRNA splicing or disrupt protein-telomere binding in conserved domains, leading to increased telomere length.

Conclusions:

• Germline loss-of-function variants in POT1 are a significant predisposing factor for familial melanoma.
• POT1 variants contribute to melanoma development through direct disruption of telomere maintenance.
• These findings expand the spectrum of genes associated with hereditary melanoma and highlight the role of telomere biology in cancer predisposition.